Estrogens and Prostate Cancer: Etiology, Mediators, Prevention, and Management
- 1 September 2011
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 40 (3) , 591-614
Abstract
No abstract availableKeywords
This publication has 248 references indexed in Scilit:
- Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat modelThe Journal of Nutritional Biochemistry, 2011
- ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason GradingCancer Cell, 2010
- Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrestCell Death & Differentiation, 2010
- Bisphenol A: Perinatal exposure and body weightMolecular and Cellular Endocrinology, 2009
- Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and NutritionBritish Journal of Cancer, 2009
- The Coffey Lecture: Steroidogenic enzyme inhibitors and hormone dependent cancerUrologic Oncology: Seminars and Original Investigations, 2009
- A potential paradox in prostate adenocarcinoma progression: Oestrogen as the initiating driverEuropean Journal of Cancer, 2008
- The role of estrogens and estrogen receptors in normal prostate growth and diseaseSteroids, 2008
- Developmental exposure to bisphenol A increases prostate cancer susceptibility in adult rats: epigenetic mode of action is implicatedFertility and Sterility, 2008
- Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble ratCarcinogenesis, 2001